Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib

OBJECTIVES: The purpose of this study was to assess osimertinib-associated cardiac adverse events (AEs) in a real-world setting, using a retrospective single-center cohort study in Japan. BACKGROUND: Cases of osimertinib-associated cardiac AEs have been reported but remain poorly understood. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunimasa, Kei, Kamada, Risa, Oka, Toru, Oboshi, Makiko, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Nishikawa, Tatsuya, Yasui, Taku, Shioyama, Wataru, Nishino, Kazumi, Imamura, Fumio, Kumagai, Toru, Fujita, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352275/
https://www.ncbi.nlm.nih.gov/pubmed/34396203
http://dx.doi.org/10.1016/j.jaccao.2020.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352275/
https://www.ncbi.nlm.nih.gov/pubmed/34396203
http://dx.doi.org/10.1016/j.jaccao.2020.02.003

Ejemplares similares